Fort Mason Partners

Fort Mason Partners is a venture capital and investment management firm based in San Francisco, California, with a specialized focus on the life sciences and healthcare sectors. The firm primarily invests in early-stage biotechnology and medical technology companies, providing the necessary capital and strategic oversight to advance clinical programs. Fort Mason Partners has historically targeted high-impact therapeutic areas, including infectious diseases and otology, through significant positions in companies like Achaogen and Otonomy. Led by Managing Director Daniel Friedland, the firm leverages deep industry expertise to support its portfolio companies through various stages of growth and regulatory milestones. While it does not develop its own proprietary drugs, it remains an influential entity in the biotech investment landscape.